Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients
Authors:
- Demetrios J. KutsogiannisDKDemetrios J. Kutsogiannis
- R.T.Noel GibneyRGR.T.Noel Gibney
- Daniel StolleryDSDaniel Stollery
- Jun GaoJGJun Gao
- 1 June 2005
- journal article
- clinical trial
- Published by Elsevier in Kidney International
- Vol. 67 (6) , 2361-2367
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- The Epidemiology of Sepsis in the United States from 1979 through 2000New England Journal of Medicine, 2003
- The first international consensus conference on continuous renal replacement therapyKidney International, 2002
- Current Canadian Approaches to Dialysis for Acute Renal Failure in the ICUAmerican Journal of Nephrology, 2002
- Regional citrate anticoagulation in continuous venovenous hemodiafiltrationAmerican Journal of Kidney Diseases, 2000
- Current Status of Renal Replacement Therapy for Acute Renal FailureAmerican Journal of Nephrology, 1999
- Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleedingKidney International, 1999
- Continuous renal replacement therapies: An updateAmerican Journal of Kidney Diseases, 1998
- Epidemiology of acute renal failure: A prospective, multicenter, community-based studyKidney International, 1996
- Prognosis of Patients With Acute Renal Failure in the Intensive-Care Unit: A Tale of Two ErasMayo Clinic Proceedings, 1996
- Acute renal failure in intensive care units--Causes, outcome, and prognostic factors of hospital mortalityCritical Care Medicine, 1996